Second Genome, Inc.
Biotechnology company · San Francisco, California, United States
Second Genome, Inc. is a biotechnology company headquartered in San Francisco, California, United States. Its earliest recorded incorporation is in 2009. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $2.1 million in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2011.
Second Genome at a glance
What does Second Genome do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $2.1 million in total (2017 to 2019). NIH funding came from the National Institute on Drug Abuse.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $5 million sold (2011).
Frequently asked questions about Second Genome
Where is Second Genome headquartered?
Second Genome, Inc. is headquartered in San Francisco, California, United States.
What does Second Genome do?
Second Genome, Inc. is a biotechnology company.
When was Second Genome founded?
The earliest incorporation on record for Second Genome, Inc. is in 2009, according to public company registers.
Similar companies
- Ossium Health, Inc.San Francisco, California, United States
- Vir Biotechnology, Inc.San Francisco, California, United States
- Titan Pharmaceuticals IncSan Francisco, California, United States
- Senti Biosciences, Inc.San Francisco, California, United States
- Amygdala Neurosciences IncSan Francisco, California, United States
- Excision BioTherapeutics IncSan Francisco, California, United States
- ProLynx, Inc.San Francisco, California, United States
- Revel Pharmaceuticals Inc.San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences